Receptors, Dopamine D2DopamineReceptors, Dopamine D1Receptors, DopamineDopamine AntagonistsReceptors, Dopamine D3Dopamine AgonistsApomorphineSulpirideBenzazepinesReceptors, Dopamine D4RemoxiprideSpiperoneHaloperidolDopaminergic Neurons2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepineReceptors, CatecholamineDomperidoneCorpus StriatumReceptors, Dopamine D5FlupenthixolDopamine AgentsAdrenergic AntagonistsDopamine Plasma Membrane Transport ProteinsClozapineQuinpiroleRacloprideAntipsychotic AgentsSalicylamidesSubstantia NigraDopamine Uptake InhibitorsCatecholaminesMesencephalonTyrosine 3-MonooxygenaseDose-Response Relationship, DrugBrainRats, WistarOxidopamineNeostriatumNucleus AccumbensLevodopaNeuronsDopamine beta-HydroxylaseCocaineAmphetamineRats, Sprague-DawleyVentral Tegmental AreaParkinsonian Disorders1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridineDopamine and cAMP-Regulated Phosphoprotein 32Parkinson DiseaseBehavior, AnimalMotor ActivityHomovanillic AcidMPTP PoisoningBromocriptineErgolinesParkinson Disease, SecondaryCaudate NucleusTetrahydronaphthalenesCatalepsyPutamenMethamphetamineMicrodialysisRewardDihydroxyphenylalaninePyrrolidinesAntiparkinson AgentsPrefrontal CortexVesicular Monoamine Transport ProteinsButaclamolBasal Ganglia1-Methyl-4-phenylpyridiniumalpha-MethyltyrosineTropanesYawning3,4-Dihydroxyphenylacetic AcidRadioligand AssayLimbic SystemTegmentum MesencephaliStereotyped BehaviorAdrenergic AgentsCentral Nervous System StimulantsNomifensineNerve Tissue ProteinsNuclear Receptor Subfamily 4, Group A, Member 2PergolideAnalysis of VarianceSerotoninConditioning, OperantDyskinesia, Drug-InducedSynaptic TransmissionMice, Inbred C57BLLisuridePiperazinesalpha-SynucleinHyperkinesisBiogenic MonoaminesPositron-Emission TomographyBrain Chemistry